Free Trial
NASDAQ:ZIVO

ZIVO Bioscience (ZIVO) Stock Price, News & Analysis

ZIVO Bioscience logo
$16.00 +0.23 (+1.46%)
As of 09:30 AM Eastern

About ZIVO Bioscience Stock (NASDAQ:ZIVO)

Key Stats

Today's Range
$16.00
$16.00
50-Day Range
$15.75
$21.49
52-Week Range
$3.13
$22.15
Volume
280 shs
Average Volume
1,029 shs
Market Capitalization
$60.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

Remove Ads
Receive ZIVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZIVO Bioscience and its competitors with MarketBeat's FREE daily newsletter.

ZIVO Stock News Headlines

[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.
Harmony Biosciences Holdings
Regencell Bioscience Holdings Ltd RGC
See More Headlines

ZIVO Stock Analysis - Frequently Asked Questions

ZIVO Bioscience's stock was trading at $21.50 on January 1st, 2025. Since then, ZIVO shares have decreased by 25.6% and is now trading at $16.00.
View the best growth stocks for 2025 here
.

ZIVO Bioscience, Inc. (NASDAQ:ZIVO) released its quarterly earnings data on Monday, May, 11th. The biotechnology company reported ($0.06) earnings per share (EPS) for the quarter. The biotechnology company earned $0.02 million during the quarter.

Shares of ZIVO Bioscience reverse split before market open on Friday, October 27th 2023. The 1-6 reverse split was announced on Friday, October 27th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Shares of ZIVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ZIVO Bioscience investors own include Canopy Growth (CGC), Meta Platforms (META), OPKO Health (OPK), Johnson & Johnson (JNJ), ACADIA Pharmaceuticals (ACAD), Aravive (ARAV) and Alibaba Group (BABA).

Company Calendar

Last Earnings
5/11/2020
Today
4/07/2025
Next Earnings (Estimated)
5/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ZIVO
Previous Symbol
OTCMKTS:HEPI
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-7,780,000.00
Pretax Margin
-17,113.75%

Debt

Sales & Book Value

Annual Sales
$15,850.00
Price / Cash Flow
N/A
Book Value
($0.81) per share
Price / Book
-19.47

Miscellaneous

Free Float
2,911,000
Market Cap
$59.78 million
Optionable
Not Optionable
Beta
-0.09

Social Links

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (NASDAQ:ZIVO) was last updated on 4/7/2025 by MarketBeat.com Staff
From Our Partners